A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

  1. Parellada, M.
  2. San José Cáceres, A.
  3. Palmer, M.
  4. Delorme, R.
  5. Jones, E.J.H.
  6. Parr, J.R.
  7. Anagnostou, E.
  8. Murphy, D.G.M.
  9. Loth, E.
  10. Wang, P.P.
  11. Charman, T.
  12. Strydom, A.
  13. Arango, C.
Revista:
Frontiers in Psychiatry

ISSN: 1664-0640

Ano de publicación: 2021

Volume: 12

Tipo: Artigo

DOI: 10.3389/FPSYT.2021.701729 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus